beta- and alpha-Adrenoceptor antagonism by medroxalol in healthy volunteers: relationship to dose and plasma concentration.
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000097:blood*; D000319:Adrenergic beta-Antagonists / Q000097:blood*; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D004562:Electrocardiography; D004983:Ethanolamines / Q000097:blood / Q000494:pharmacology*; D005080:Exercise Test; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000037:antagonists & inhibitors*; D008297:Male; D010656:Phenylephrine / Q000037:antagonists & inhibitors*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D010656:Phenylephrine; C024892:medroxalol; D007545:Isoproterenol